PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 63 filers reported holding PRELUDE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $4,485,000 | – | 650 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 10,039,691 | $66,362,000 | 1.23% |
Baker Brothers Advisors | 10,123,824 | $66,918,000 | 0.44% |
HHLR ADVISORS, LTD. | 583,333 | $3,856,000 | 0.10% |
CAXTON ASSOCIATES LP | 85,992 | $568,000 | 0.08% |
Virtus ETF Advisers LLC | 24,180 | $160,000 | 0.06% |
GSA CAPITAL PARTNERS LLP | 54,173 | $358,000 | 0.05% |
DENALI ADVISORS LLC | 8,200 | $54,000 | 0.03% |
PDT Partners, LLC | 12,641 | $84,000 | 0.01% |
UBS ASSET MANAGEMENT AMERICAS LLC | 2,402,595 | $15,881,153,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 36,949 | $244,000 | 0.01% |